Adult tissue stem cells maintain and repair tissues by regulating an increased number of committed progenitor cells. However, the mechanisms that control adult stem cell homeostasis remain poorly understood, especially those involved during aging. A decline in tissue regenerative capacity and organ homeostasis is a major feature of aging that is associated with impaired stem cell function.^[@bib1],\ [@bib2],\ [@bib3]^ Hematopoietic stem cells (HSCs) are well-characterized stem cells that have the highest self-renewal capacity and differentiation potential into hematopoietic progenitor and precursor cells.^[@bib4]^ In aged mice, HSCs alter homing and mobilization properties, diminish the competitive repopulating ability and shift the lineage potential from lymphopoiesis toward myelopoiesis.^[@bib5]^ However, how HSCs change with aging is not clear. It has been suggested that cell intrinsic and extrinsic factors can regulate stem cell function during aging.^[@bib6],\ [@bib7]^ Cell intrinsic alterations, such as DNA damage, oxidative stress and senescence, are associated with and most likely contribute to HSC aging.^[@bib8]^ The changes in environmental cues mediated via cell--cell interactions, cytokines and growth factors may also markedly contribute to age-dependent hematopoietic dysfunction.^[@bib9],\ [@bib10]^

Caveolae are specialized invaginations of the plasma membrane that are implicated in a number of diverse cellular functions, such as signal transduction, lipid regulation, endocytosis and tumorigenesis.^[@bib11]^ The major structural components of caveolae consist of the Cav (Cav-1, Cav-2 and Cav-3) and the Cavin (PTRF/Cavin-1, SDPR/Cavin-2, SRBC/Cavin-3 and MURC/Cavin-4) families.^[@bib11],\ [@bib12],\ [@bib13],\ [@bib14]^ Cav-1 and Cav-2 are co-expressed and form a hetero-oligomeric complex in many cell types.^[@bib15]^

Cav-1 is a major structural component of caveolae membranes and deletion of Cav-1 results in a nearly complete loss of caveolae. Young Cav-1^−/−^ mice are viable and fertile; however, at 27--65 weeks of age, these mice decline in viability.^[@bib16]^ Loss of Cav-1 accelerates neurodegeneration and aging,^[@bib17]^ and recent studies revealed that Cav-1 has a role in regulating neural stem cell (NSC) and embryonic stem cell (ESC) proliferation. Cav-1 increases NSC proliferation in the subventricular zone of the adult mouse brain,^[@bib18]^ and Cav-1 and integrin *β*1 regulate ESC proliferation via p38 MAPK and FAK in high-glucose conditions.^[@bib19]^ However, the role of Cav-1 in HSCs function has not been investigated. Additionally, Cav-1 has a critical role in the differentiation of monocytes into macrophages.^[@bib20]^ And Cav-1 is regulated in B lymphocytes by LSP and involved in the development of T-independent immune responses. The data suggest that Cav-1 may have an important role in the regulation of immune responses.^[@bib21]^ Together, Cav-1 could play an important role in the regulation of HSCs function.

In this study, we used Cav-1 knockout mice to investigate the effect of Cav-1 on HSC self-renewal and proliferation during aging. We found that Cav-1-deficient mice exhibited impaired HSC/HPC development. *In vitro* and *in vivo* assays showed that the deletion of Cav-1-disrupted HSC function. In addition, HSCs from Cav-1 knockout mice increased reactive oxygen species (ROS) production and the percentage of cycling cells.

Results
=======

Cav-1 knockout mice display a decreased number of B lymphocytes
---------------------------------------------------------------

We first examined Cav-1 expression in the bone marrow (BM), spleen and thymus using RT-PCR and western blotting. Our results confirmed the absence of Cav-1 expression in Cav-1^−/−^ mice ([Figures 1a and b](#fig1){ref-type="fig"}). We then measured the spleen weight and found that the spleen was larger in Cav-1^−/−^ mice compared with Cav-1^+/+^ mice ([Figure 1c](#fig1){ref-type="fig"}). However, there were no apparent pathological changes between Cav-1^+/+^ and Cav-1^−/−^ mice, and there was no changes of the splenic white pulp ([Supplementary Figures 2a and b](#sup1){ref-type="supplementary-material"}). We used FACS analysis to determine the percentage of B cells (B220^+^), T cells (CD3^+^) and M cells (monocytes and granulocytes, CD11B^+^ and Gr-1^+^) in the peripheral blood of 2-month (mo)-, 6-mo- and 12-mo-old mice. In Cav-1^−/−^ mice, the percentage of mature B cells was reduced with aging ([Figure 1d](#fig1){ref-type="fig"}), and the percentage of M cells was increased in 12-mo-old mice ([Supplementary Figure 1a](#sup1){ref-type="supplementary-material"}). However, no significant changes in the percentage of mature T cells ([Figure 1d](#fig1){ref-type="fig"}) between Cav-1^+/+^ and Cav-1^−/−^ mice were observed. We also used FACS analysis to determine if any changes in the percentage of B cells, T cells and M cells in the BM, spleen and thymus occurred. In Cav-1^−/−^ mice, the percentage of B cells in the BM was reduced with aging ([Figure 1e](#fig1){ref-type="fig"}), whereas the percentage of B cells in the spleen was not significantly decreased ([Supplementary Figure 2c](#sup1){ref-type="supplementary-material"}). The percentage of M cells in the BM was increased in Cav-1^−/−^ mice ([Supplementary Figure 1a](#sup1){ref-type="supplementary-material"}), but no significant changes in the percentage of T cells in the BM, thymus or spleen of Cav-1^−/−^ mice was evident ([Supplementary Figures 1b and 2c](#sup1){ref-type="supplementary-material"}). Cav-1^−/−^ mice had a reduced percentage of B cells and an increased percentage of M cells in the BM and PB, which was similar to what was observed during aging of WT mice.^[@bib8],\ [@bib22]^

Cav-1^−/−^ mice display hematopoietic stem/progenitor cell defects
------------------------------------------------------------------

Given that the percentage of B cells decreased and the percentage of M cells increased in the BM and PB of Cav-1^−/−^ mice, we investigated whether this shift was related to an alteration in the stem/progenitor cell populations. We analyzed the LSK (Lin^−^Sca1^+^c-kit^+^) BM cell population of 2-mo- and 12-mo-old Cav-1^+/+^ and Cav-1^−/−^ mice using FACS. The data showed that Cav-1^−/−^ mice had a higher percentage of LSK cells within the total BM cell population that resulted in two- or threefold increases in the absolute number of LSKs ([Figures 2a and b](#fig2){ref-type="fig"}). During aging, the differences between Cav-1^+/+^ and Cav-1^−/−^ mice became more pronounced ([Figure 2c](#fig2){ref-type="fig"}). The numbers of LT-HSCs (long-term HSCs, Lin^−^Sca-1^+^c-Kit^+^CD34^−^Flt-3^−^), ST-HSCs (short-term HSCs, Lin^−^Sca-1^+^c-Kit^+^CD34^+^ Flt-3^−^) and MPPs (multipotent progenitors, Lin^−^Sca-1^+^c-Kit^+^Flt-3^+^) were also detected using FACS ([Figure 2a](#fig2){ref-type="fig"}).^[@bib23]^ Cav-1^−/−^ BM LSKs contained increased frequencies of LT-HSCs, but a marked increased frequency of ST-HSCs. When the measured frequencies were converted to absolute cell numbers, a marked increase of each population was noted ([Figures 2b and c](#fig2){ref-type="fig"}). The increase in the numbers of HSCs and LT-HSCs in Cav-1^−/−^ mice was more pronounced in 12-mo-old mice ([Figure 2c](#fig2){ref-type="fig"}).

Further differentiation of HSCs gives rise to common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs) in the BM. CLPs are derived from c-Kit^low^Sca-1^low^Lin^−^ cells based on the expression of CD127.^[@bib24],\ [@bib25]^ In Cav-1^−/−^ mice, a significant reduction in the frequency and absolute number of CLPs was observed ([Figures 2d and e](#fig2){ref-type="fig"}).

CMPs are derived from c-Kit^+^Sca-1^−^Lin^−^ cells and can be further divided based on their CD34 and CD16/CD32 expression into common myeloid progenitors (CMPs; CD34^+^CD16/CD32^−^), granulocyte-macrophage progenitors (GMPs; CD34^+^CD16/CD32^+^) and megakaryocyte-erythroid progenitors (MEPs; CD34^−^CD16/CD32^−^) ([Figure 2f](#fig2){ref-type="fig"}). In contrast, despite the reduced frequency of stem/progenitor cells, the frequency of myeloid progenitors (GMPs, EMPs and CMPs) in Cav-1^−/−^ mice was not significantly reduced compared with that of Cav-1^+/+^ mice ([Figures 2g and h](#fig2){ref-type="fig"}).

Thus, the reduction of lymphoid populations, but not myeloid progenitor cell populations, and the increase of HSCs in Cav-1^−/−^ mice resembled the change in HSCs/HPCs and lymphoid populations that was previously described in Bmi-1^−/−[@bib24]^ and Ews^−/−[@bib26]^ mice, all of which exhibit aging-like phenotypes.

Cav-1^−/−^ mice display disrupted HSC function
----------------------------------------------

To investigate whether Cav-1 affects the proliferation and/or differentiation of HSCs and other cells, we performed *in vitro* clonogenic assays. We examined the clonogenic potential of LT-HSCs, BM and spleen cells derived from Cav-1^+/+^ and Cav-1^−/−^ mice. For the LT-HSCs, we sorted the Lin^−^Sca-1^+^c-Kit^+^CD34^−^Flt-3^−^ cells using FACS and then plated the cells in a methylcellulose-based medium. Fourteen days after plating, the colonies were counted using a microscope. Cells from Cav-1^−/−^ mice displayed a reduced number of colonies compared with cells from Cav-1^+/+^ mice ([Figure 3a](#fig3){ref-type="fig"}). The decrease in colony size and number suggested a defect in the self-renewal of the LT-HSCs. We also sorted cells from the BM and spleen and found that the colony size and number were decreased in Cav-1^−/−^ mice ([Supplementary Figures 2d and e](#sup1){ref-type="supplementary-material"}), which suggested that the deletion of *Cav-1* influences the proliferation and/or differentiation of BM and spleen cells.

We performed *in vivo* competitive repopulation experiments. BM cells from Cav-1^+/+^ or Cav-1^−/−^ mice (CD45.2^+^) were mixed at a ratio of 1 : 1 with competitor BM cells (CD45.1^+^45.2^+^) and injected into lethally irradiated CD45.1^+^-recipient mice. Flow cytometry analysis was used to determine the number of CD45.2^+^-positive cells in the peripheral blood 2, 6, 10 and 14 weeks after transplantation. The results showed that cells derived from Cav-1^−/−^ mice exhibited a severe defect in the ability to reconstitute hematopoiesis in irradiated recipients ([Figures 3b and c](#fig3){ref-type="fig"}).

To examine whether Cav-1 modulates the lineage of HSCs, at 14 weeks after transplantation, we used FACS to analyze the number of B and M cells in recipient mice. The results showed that in recipient mice transplanted with cells from Cav-1^−/−^ mice, the chimerism of donor-derived B cells was decreased ([Figure 3d](#fig3){ref-type="fig"}), but that of donor-derived M cells was increased ([Figure 3e](#fig3){ref-type="fig"}). The number of LSKs was increased in recipient mice transplanted with cells from Cav-1^−/−^ mice ([Figure 3f](#fig3){ref-type="fig"}). Thus, irradiated recipients of Cav-1-deficient cells failed to reconstitute hematopoiesis, and the function of LSKs was impacted.

Cav-1^−/−^ cells induce a loss of HSC quiescence
------------------------------------------------

The quiescence of HSCs has an indispensable role in the maintenance of the HSC pool throughout life, and disruption of HSC quiescence leads to the premature depletion of stem cells. The observed decrease in the frequency of HSCs in Cav-1^−/−^ mice raised the possibility that *Cav-1* deletion compromised the quiescence of HSCs, which would lead to a reduction of the stem/progenitor cell size. To test this possibility, we characterized the cell cycle status of the stem/progenitor cells. We analyzed the proliferation of the LSK population using the cell marker Ki-67 and DNA content using the DNA dye 7-AAD. Cell cycle analysis showed that the percentage of cells in G0 phase was reduced, and more cells entered the G1 and G2/M phases. This result indicated that the deletion of *Cav-1* promotes stem cell exit from a quiescent state and entrance into G1 phase of the cell cycle, which is one of the common features found in HSCs from aged mice ([Figures 4a and b](#fig4){ref-type="fig"}).

Oxidative stress is a critical determinant of HSC lifespan and self-renewal, and the loss of HSC quiescence frequently correlates with increased cellular ROS.^[@bib27]^ Consistent with this, Cav-1^−/−^ HSCs displayed higher levels of ROS than Cav-1^+/+^ HSCs. Thus, the increased ROS levels may induce the disrupted HSCs quiescence in Cav-1^−/−^ mice ([Figures 4c and d](#fig4){ref-type="fig"}).

Cav-1 deletion regulates several genes involved in cell cycle control and cellular senescence
---------------------------------------------------------------------------------------------

Alterations in the HSCs function that is associated with Cav-1 deficiency can result in changes in the expression levels of key regulator genes. We sorted LSKs from Cav-1^+/+^ and Cav-1^−/−^ mice using FACS and used real-time PCR analysis to investigate several genes involved in the cell cycle, cellular senescence and HSC regulation.

No changes were observed in the expression levels of the cell cycle regulators p18 and p19 or in the Notch 1 pathway. However, Bmi-1, CXCR4 and p57 expression levels were downregulated in LSKs from Cav-1^−/−^ mice, whereas the expression levels of the cellular senescence-associated proteins p16 and p21 were slightly upregulated ([Figure 5](#fig5){ref-type="fig"}). Taken together, these data indicate that several key regulators involved in the cell cycle, self-renewal, cellular senescence and adhesion may coordinate to regulate HSC function in Cav-1^−/−^ mice.

Cav-1 influences the environment of HSCs
----------------------------------------

Intrinsic and extrinsic cellular factors can regulate stem cell function during aging. To investigate whether Cav-1 alters the HSC environment, we transplanted BM cells from 2-mo-old RFP transgenic mice into cohorts of irradiated Cav-1^+/+^ and Cav-1^−/−^ littermates. Four months after transplantation, the RFP+ cell chimerism in the peripheral blood was not significantly different between the Cav-1^+/+^- and Cav-1^−/−^-transplanted mice ([Figure 6a](#fig6){ref-type="fig"}). However, the percentage of B and T cells in Cav-1^−/−^-transplanted mice was decreased compared with the Cav-1^+/+^-transplanted mice ([Figure 6b](#fig6){ref-type="fig"}). In the BM of Cav-1^−/−^-transplanted mice, the frequency of B cells was also significantly reduced ([Figure 6c](#fig6){ref-type="fig"}), whereas the number of LSK cells was still increased ([Figure 6d](#fig6){ref-type="fig"}). These data suggested that deletion of Cav-1 resulted in a disruption of the HSC environment, which induced the proliferation but impaired the function of HSCs.

Discussion
==========

In this study, we showed that Cav-1 has an important role in regulating HSC function. Cav-1^−/−^ mice displayed a decreased percentage of B cells and an increased percentage of M cells in the BM and PB, and these changes were due to an increased number of HSCs. *In vitro* and *in vivo* assays showed that HSCs from Cav-1^−/−^ mice decreased the ability to self-renew and reconstitute hematopoiesis, and Cav-1 deletion disrupted the quiescence of LSKs and increased the level of produced ROS. However, Cav-1 deletion induced alterations in the HSC environment, increased HSC numbers and disrupted the ability of those HSCs to differentiate into mature blood cells.

It has been revealed that intrinsic and extrinsic cellular factors can contribute to a decline in stem cell function. Tight regulation of the cell cycle of HSCs is important for their function, and studies had implicated numerous factors in the regulation of the cell cycle status. However, how these factors interact to maintain the balance between HSCs quiescence and proliferation is an open question.^[@bib28],\ [@bib29]^ Cav-1 inhibits the transcription of genes, such as cyclin D1, that are regulated during cell cycle progression.^[@bib30]^ We showed that the cyclin-dependent kinase inhibitor p57, which was identified as a potential regulator of HSC quiescence,^[@bib31]^ was downregulated in BM from Cav-1^−/−^ mice. This change might disrupt the quiescence of HSC and promote cell cycle progression.

Additionally, Cav-1 modulated signal transduction by attracting signaling molecules to caveolae and regulating their activity. Many proteins, such as TGFβR, PKC and the insulin receptor,^[@bib6],\ [@bib15],\ [@bib32]^ that interacted with Cav-1 are involved in HSCs regulation. Thus, Cav-1 deletions may impact the interaction between cells and cytokines, which are growth factors that are associated with HSCs function.

The degree of oxidative damage has been found to increase with age in a variety of cells and tissues. Excess accumulation of ROS impacts cellular senescence, and the amount of ROS is a critical determinant of HSC lifespan and self-renewal. ROS are particularly deleterious to HSCs, especially as they age.^[@bib33],\ [@bib34],\ [@bib35]^ Loss of LT-HSC quiescence frequently correlates with increased cellular ROS, which is negatively associated with HSC self-renewal.^[@bib27]^ Cav-1 acts as a scaffolding protein that concentrates and functionally regulates signaling molecules, and the loss of Cav-1 was identified as a marker of the cancer-associated fibroblast phenotype.^[@bib36]^ Different types of ROS have different effects on Cav-1 expression, cell migration and invasion. Superoxide anion and hydrogen peroxide downregulated Cav-1 expression and inhibited cell migration and invasion, whereas hydroxyl radicals upregulated Cav-1 expression and promoted cell migration and invasion.^[@bib37]^ In this study, we found that Cav-1 deletion induced an increase in the level of produced ROS, and this increased production of ROS could be the reason for the loss of HSC function.

Taken together, these results indicate that deletion of Cav-1 induced alterations in the HSC environment and increased HSC numbers, but disrupted the ability of HSCs to differentiate into mature blood cells.

Materials and Methods
=====================

Animals
-------

Cav-1 knockout mice were obtained from the Jackson Laboratory (Sacramento, CA, USA) (strain name: STOCK Cav1^tm1Mls^/J), and the RFP transgenic mice were established in our laboratory. All of the mice had the C57BL/6J genetic background, and all were maintained in a pathogen-free environment and fed a standard diet. The use of animals was approved by the Animal Care and Use Committee of the Institute of Laboratory Animal Science of Peking Union Medical College.

Flow cytometry
--------------

BM cells were flushed from tibias and femurs with PBS. The cells were filtered using a sterile nylon mesh and counted before staining with the indicated antibodies.

In most cases, the cells were stained using a biotin-conjugated anti-mouse CD4 (RM4--5), CD5 (53--7.3), CD8a (53--6.7), CD11b (M1/70), B220 (RA3--6B2), TER119 (TER-119) or Gr1 (RB6--8C5) antibody; and this was followed by staining with an APC-eFluor780-conjugated Streptavidin secondary antibody. The antibodies used for surface staining were as follows: PE CD71 (R17217), APC TER-119 (TER-119), PE-Cy7 B220 (RA3--6B2), APC IgM (II/41), FITC IgD (11--26), PE-Cy7 Sca-1 (D7), PE Flt3 (A2F10), FITC B220 (RA3--6B2), FITC CD34 (RAM34), PerCP-Cy5.5 CD127 (A7R34), PE CD16/CD32 (93), PerCP-Cy5.5 CD3e (145-2C11), PerCP-Cy5.5 CD45.2 (104), APC-eFluor780 CD11b, PE CD45.1 (A20) and APC CD117 (ACK2). All antibodies were obtained from eBioscience (San Diego, CA, USA).

Cell cycle analysis
-------------------

For cell cycle analysis, all isolated BM cells were stained with stem cell surface markers (Lineage, Sca-1, c-kit), fixed, permeabilized (BD Bioscience, San Jose, CA, USA) and stained with a FITC Ki-67 antibody and 7-AAD. Data acquisition was performed using a FACSAria I cell sorter (Becton-Dickinson, Franklin Lakes, NJ, USA), and the acquired data were analyzed using FlowJo software (Treestar, Ashland, OR, USA).

Determination of ROS production
-------------------------------

Cells were incubated with DCFH-DA (Beyotime Company, Hangzhou, China) at 37 °C for 20 min. DCFH-DA passively diffused into the cells and was deacetylated by esterases to form nonfluorescent 2′,7′-dichlorofluorescein (DCFH). The amount of emitted fluorescence correlated with the quantity of ROS in the cell. Data acquisition was performed using a FACSAria I cell sorter (Becton-Dickinson), and the acquired data were analyzed using FlowJo software.

Competitive transplantation
---------------------------

In the competitive transplantation assays, BM cells (2 × 10^6^) from 2-mo-old competitor (CD45.1^+^45.2^+^) mice were mixed with CD45.2^+^ donor BM cells in a 1 : 1 ratio and transplanted into CD45.1^+^ lethally irradiated host mice. The donor-derived chimerisms in the peripheral blood and BM were determined using FACS analysis 2, 6, 10 and 14 weeks after transplantation.

Real-time PCR
-------------

Total RNA was extracted from cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer\'s instructions. The genes of interest were amplified from DNase I-treated, total RNAs using M-MLV Reverse Transcriptase (Promega, Madison, WI, USA) and polydT primers. The primers that were used for PCR were as follows: Cav-1 (5′-GACCCCAAGCATCTCAACGAC-3′ and 5′-GGATCGCAGAAGGTATGGACG-3′, Tm=62 °C, 27 cycles), c-myc (5′-CTGGATTTCCTTTGGGCGTT-3′ and 5′-AATAGGGCTGTACGGAGTCG-3′, Tm=61 °C, 30 cycles), CXCR4 (5′-ATGGAACCGATCAGTGTGAG-3′ and 5′-AAGTAGATGGTGGGCAGGAA-3′, Tm=62 °C, 35 cycles), p18 (5′-GGGACCTAGAGCAACTTACT-3′ and 5′-TGACAGCAAAACCAGTTCCA-3′, Tm=61 °C, 30 cycles), p21^*waf1/cip1*^ (5′-TCCAGACATTCAGAGCCACA-3′ and 5′-CGAAGAGACAACGGCACACT-3′, Tm=60 °C, 30 cycles), p19 (5′-ATGGGTCGCAGGTTCTTGGT-3′ and 5′-GTAGTGGGGTCCTCGCAGTT-3′, Tm=61 °C, 35 cycles), p27 (5′-TCTCAGGCAAACTCTGAGGAC-3′ and 5′-TTCGGAGCTGTTTACGTCTGG-3′, Tm=61 °C, 30 cycles), Notch 1 (5′-CAGCCACAGGAACTTACCACTCCAG-3′ and 5′-TAAATGCCTCTGGAATGTGGGTGAT-3′, Tm=57 °C, 35 cycles), Bmi-1 (5′-AGCAGCAATGACTGTGATGCACTTGAG-3′ and 5′-GCTCTCCAGCATTCGTCAGTCCATCCC-3′, Tm=57 °C, 35 cycles), p53 (5′-CATGAACCGCCGACCTATC-3′ and 5′-TCCCGGAACATCTCGAGGC-3′, Tm=62 °C, 35 cycles), p16 (5′-CGAACTCTTTCGGTCGTACCC-3′ and 5′-CGAATCTGCACCGTAGTTGAGC-3′, Tm=62 °C, 35 cycles), p57^*kip2*^ (5′-AGGAGCAGGACGAGAATCAA-3′ and 5′-TTCTCCTGCGCAGTTCTCTT-3′, Tm=61 °C, 30 cycles), GAPDH (5′-GAGCGAGACCCCACTAACAT-3′ and 5′-TTCACACCCATCACAAACAT-3′, Tm=60 °C, 25 cycles). Real-time PCR using SYBR Premix Ex Taq II (TaKaRa, Shiga, Japan) was carried out using the ABI StepOne detection system (Applied Biosystems, Foster City, CA, USA).

Western blotting
----------------

For western blots, cell lysates were prepared in RIPA buffer (50 m[M]{.smallcaps} Tris-Cl (pH 8.0), 100 m[M]{.smallcaps} NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40) with a protease inhibitor cocktail (Roche, Reutlingen, Germany). Total protein concentrations were measured using a BCA kit, and immunoblotting of the clarified cell extracts was performed using 12% SDS-polyacrylamide gels. The proteins were transferred to nitrocellulose membranes (Millipore, Darmstadt, Germany) and incubated at 4 °C overnight with the Cav-1 antibody (BD). An HRP-conjugated anti-rabbit secondary antibody was used for detection with a chemiluminescent detection system (Santa Cruz Biotechnology, Santa Cruz, CA, USA).

Clonogenic assays
-----------------

Cells were plated in a methylcellulose-based medium (R&D, HSC007). For LT-HSCs, we used 96-well cell culture plates (5 cells/well), with each sample added to 10 wells. For BM and spleen cells, we used 24-well cell culture plate (10^4^ cells/well), with each sample added to six wells. Two weeks after plating, the colonies were counted using a microscope.

Statistics
----------

Data were analyzed using Microsoft Excel and GraphPad Prism software (GraphPad Software, San Diego, CA, USA). Differences were considered to be significant at *P*\<0.05, as analyzed by Student\'s *t*-test. Error bars represent S.D. in all figures.
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![The percentage of B cells from the peripheral blood, BM and spleen was decreased in Cav-1^−/−^ mice. (**a**) Expression of the Cav-1 protein in the BM, spleen and thymus was detected using real-time PCR. (**b**) Expression of the Cav-1 protein in the BM was detected using western blotting. (**c**) The weight of the spleen from Cav-1^+/+^ and Cav-1^−/−^ mice. (**d**) FACS analysis of the percentage of B and T cells in the peripheral blood from 2-mo-, 6-mo- and 12-mo-old mice. (**e**) FACS analysis of the percentage of B cells in the BM from 2-mo-, 6-mo- and 12-mo-old mice; *n*=5 mice per group. The experiment was repeated three times, and the results represent the mean±s.d. \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001. GAPDH expression was used for normalization](cddis2014105f1){#fig1}

![Hematopoietic stem/progenitor cell defects in Cav-1^−/−^ mice. (**a**) Representative staining profiles for BM HSCs and progenitor populations. (**b**) Cell numbers of LSKs, LT-HSCs, ST-HSCs and MPPs in the BM from 2-mo- and 12-mo-old (**c**) mice. (**d**) Representative staining profiles for CLPs (Lin^−^Sca-1^low^c-Kit^low^CD127^+^) in the BM. (**e**) Cell numbers of CLPs in the BM from 2-mo- and 12-mo-old mice. (**f**) Representative staining profiles for myeloid progenitors. L^−^S^−^K^+^ cells were subdivided into CMPs (Lin^−^Sca-1^−^c-Kit^−^CD34^+^CD16/CD32^−^), GMPs (Lin^−^Sca-1^−^c-Kit^−^CD34^+^CD16/CD32^+^) and MEPs (Lin^−^Sca-1^−^c-Kit^−^CD34^−^CD16/CD32^−^) as indicated. (**g**) Cell numbers of CMPs, GMPs and MEPs in the BM from 2-mo- and 12-mo-old (**h**) mice. *n*=5 mice per group. The experiment was repeated three times, and the results represent the mean±s.d. \**P*\<0.05; \*\**P*\<0.01](cddis2014105f2){#fig2}

![Loss of Cav-1 impairs the clonogenic ability and function of HSCs. (**a**) *In vitro* clonogenic potential of LT cells from Cav-1^+/+^ and Cav-1^−/−^ mice (*n*=3). (**b**) The percentage of CD45.2^+^ cells in the peripheral blood of irradiated recipient mice 2, 4, 8 and 12 weeks after transplantation with either Cav-1^+/+^ or Cav-1^−/−^ cells (**c**) that were mixed at a 1 : 1 ratio with BM cells from competitors. (**d**) The percentage of donor-derived B and M cells (**e**) of either Cav-1^+/+^ or Cav-1^−/−^ mice in the BM of recipient mice 12 weeks after transplantation. (**f**) The percentage of donor-derived LSK cells in the BM of recipient mice 12 weeks after transplantation. *n*=9 mice per group. The results represent the mean±s.d. \**P*\<0.05; \*\**P*\<0.01](cddis2014105f3){#fig3}

![Deletion of Cav-1 induces a loss of HSC quiescence and accelerates cellular senescence. (**a**) FACS analysis of 7-AAD and Ki-67 staining of LSKs from Cav-1^+/+^ or Cav-1^−/−^ mice. (**b**) The percentage of cells in each phase of the cell cycle. (**c**) FACS analysis of LSKs from Cav-1^+/+^ or Cav-1^−/−^ mice using the ROS detection reagent. (**d**) The percentage of ROS-positive cells in the LSK population; *n*=5 mice per group. The results represent the mean±s.d. \**P*\<0.05; \*\**P*\<0.01](cddis2014105f4){#fig4}

![Cav-1 deletion altered the expression pattern of a number of transcription factors, cell cycle regulatory genes and cellular senescence-associated genes in LSKs. RT-PCR analysis of the gene expression of RNA isolated from sorted LSK cells from Cav-1^+/+^ or Cav-1^−/−^ mice. GAPDH expression was used for normalization. The experiment was repeated three times, and the results represent the mean±s.d. \**P*\<0.05; \*\**P*\<0.01](cddis2014105f5){#fig5}

![The Cav-1^−/−^ environment induces the accumulation of LSK cells. (**a**) Chimerisms of RFP-derived peripheral blood cells were measured at the indicated time points after transplantation. (**b**) The percentage of RFP-derived B and T cells in the peripheral blood of Cav-1^+/+^ or Cav-1^−/−^ recipient mice 4 mo after transplantation. (**c**) The percentage of RFP-derived B cells in the BM of Cav-1^+/+^ or Cav-1^−/−^ recipient mice 4 mo after transplantation. (**d**) Cell number of RFP-derived LSK cells in the BM of Cav-1^+/+^ or Cav-1^−/−^ recipient mice 4 mo after transplantation; *n*=5 mice per group. The experiment was repeated three times, and the results represent the mean±s.d. \**P*\<0.05; \*\**P*\<0.01](cddis2014105f6){#fig6}
